Caldwell Sutter Capital, Inc.
Source: SEC Form 13F · as of Mar 2026Caldwell Sutter Capital, Inc. holds 16 biotech & pharma companies tracked by BioSniper, totaling $1.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$1.4M
BioSniper AIPage evidence connected
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 7,590 | $1.1M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 3,557 | $196K |
| BBIOBridgeBio Pharma, Inc. | 2,000 | $149K |
| PCVXVaxcyte, Inc. | 432 | $25K |
| FOLDAMICUS THERAPEUTICS, INC. | 400 | $6K |
| LPCNLipocine Inc. | 471 | $4K |
| PRLDPrelude Therapeutics Inc | 1,000 | $3K |
| ATAIAtai Beckley N.V. | 700 | $2K |
| SNYSanofi | 50 | $2K |
| OGNOrganon & Co. | 300 | $2K |
| CELUCelularity Inc. | 1,000 | $1K |
| AUTLAutolus Therapeutics plc | 500 | $690 |
| SLSSELLAS Life Sciences Group, Inc. | 100 | $423 |
| DAREDare Bioscience, Inc. | 17 | $31 |
| IMUXIMMUNIC, INC. | 3 | $3 |
| APTOFAptose Biosciences Inc. | 2 | $3 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.